NCT03113045 is a NA clinical trial of seated time in Cesarean Section Complications, sponsored by Royal Victoria Hospital, Canada.

Who is sponsoring NCT03113045?

NCT03113045 is sponsored by Royal Victoria Hospital, Canada.

What drugs are being tested in NCT03113045?

Interventions in NCT03113045: seated time.

What condition does NCT03113045 study?

NCT03113045 studies Cesarean Section Complications.

Is NCT03113045 still recruiting?

NCT03113045 is currently status unknown. Last updated 13 April 2017.

Last reviewed 2017-04-13 · How we verify

NCT03113045

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Seated Time for 90% Incidence of Hypotension

Status unknown NA Last updated 13 April 2017

What this trial tests

NA trial testing seated time in Cesarean Section Complications in 60 participants. Status unknown.

Timeline

31 January 2017

Primary endpoint
31 January 2019

31 January 2020

Quick facts

Lead sponsor	Royal Victoria Hospital, Canada
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	60
Start date	31 January 2017
Primary completion	31 January 2019
Estimated completion	31 January 2020
Sites	1 location across Canada

Drugs / interventions tested

seated time

Conditions studied

Cesarean Section Complications — all drugs for Cesarean Section Complications →

Sponsor

Royal Victoria Hospital, Canada

Who can join

Adults 18 to 50, female only, with Cesarean Section Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will determine the 90% effective seated time after intrathecal injection of hyperbaric bupivacaine to avoid hypotension in patients undergoing cesarean delivery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cesarean Section Complications

Currently open trials in the same condition.

NCT07278037 — Trends in the Administration of Tranexamic Acid for Postpartum Hemorrhage · recruiting
NCT05224726 — Platelet Rich Plasma for Uterine Scar · NA · recruiting
NCT07130747 — Effect of Myofascial Release Versus Deep Friction Massage on Abdominal Recovery and Scar After Cesarean Section · NA · recruiting
NCT05791630 — The Norwegian World Health Organisation Labour Care Guide Trial (NORWEL) · NA · recruiting
NCT07049705 — Factors Influencing Bradycardia During Spinal Anesthesia in Obstetric Patients Undergoing Cesarean Section · active not recruiting

Other Royal Victoria Hospital, Canada trials

Trials by the same sponsor.

NCT06002113 — Eliciting Informed Goals of Care in Elderly Patients · NA · recruiting
NCT05626374 — Comparing the Effect of Adding a Remote Self-reporting Tool for Distress and Fit-for-purpose Mental Health & Addictions · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03113045 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Royal Victoria Hospital, Canada
Last refreshed: 13 April 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03113045.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing